{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T10:52:17Z","timestamp":1780397537354,"version":"3.54.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020YFA0909000"],"award-info":[{"award-number":["2020YFA0909000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015377","name":"Shanghai Key Laboratory of Molecular Imaging","doi-asserted-by":"publisher","award":["18DZ2260400"],"award-info":[{"award-number":["18DZ2260400"]}],"id":[{"id":"10.13039\/501100015377","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82127807"],"award-info":[{"award-number":["82127807"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272912"],"award-info":[{"award-number":["82272912"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.yexcr.2025.114815","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T16:43:47Z","timestamp":1762274627000},"page":"114815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Berberine overcomes paclitaxel resistance in triple-negative breast cancer by inhibiting HSP90-mediated BRCA1 phosphorylation"],"prefix":"10.1016","volume":"454","author":[{"given":"Jingyi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YuQin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changlian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2025.114815_bib1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","article-title":"Breast cancer: pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.yexcr.2025.114815_bib2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","article-title":"Recent advances in therapeutic strategies for triple-negative breast cancer","volume":"15","author":"Li","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.yexcr.2025.114815_bib3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.yexcr.2025.114815_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/biom9120789","article-title":"Paclitaxel's mechanistic and clinical effects on breast cancer","volume":"9","author":"Abu Samaan","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.yexcr.2025.114815_bib5","article-title":"Paclitaxel resistance in breast cancer: current challenges and recent advanced therapeutic strategies","volume":"43","author":"Abouzeid","year":"2025","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.yexcr.2025.114815_bib6","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12951-021-00898-1","article-title":"Porphyrin-lipid stabilized paclitaxel nanoemulsion for combined photodynamic therapy and chemotherapy","volume":"19","author":"Chang","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.yexcr.2025.114815_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-008864","article-title":"Novel insights into paclitaxel's role on tumor-associated macrophages in enhancing PD-1 blockade in breast cancer treatment","volume":"12","author":"Choi","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.yexcr.2025.114815_bib8","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/s41467-024-45160-y","article-title":"The anti-PD-L1\/CTLA-4 bispecific antibody KN046 in combination with nab-paclitaxel in first-line treatment of metastatic triple-negative breast cancer: a multicenter phase II trial","volume":"15","author":"Li","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2025.114815_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107742","article-title":"Coptidis rhizoma and berberine as anti-cancer drugs: a 10-year updates and future perspectives","volume":"216","author":"Chen","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.yexcr.2025.114815_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108965","article-title":"Berberine regulates PADI4-related macrophage function to prevent lung cancer","volume":"110","author":"Gu","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.yexcr.2025.114815_bib11","doi-asserted-by":"crossref","first-page":"794","DOI":"10.7150\/ijbs.18969","article-title":"Berberine reverses hypoxia-induced chemoresistance in breast cancer through the inhibition of AMPK- HIF-1\u03b1","volume":"13","author":"Pan","year":"2017","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.yexcr.2025.114815_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113031","article-title":"Berberine sensitizes immune checkpoint blockade therapy in melanoma by NQO1 inhibition and ROS activation","volume":"142","author":"Luo","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.yexcr.2025.114815_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106817","article-title":"Berberine inhibits breast carcinoma proliferation and metastasis under hypoxic microenvironment involving gut microbiota and endogenous metabolites","volume":"193","author":"Sun","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.yexcr.2025.114815_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217019","article-title":"Unlocking the potential of berberine: advancing cancer therapy through chemosensitization and combination treatments","volume":"597","author":"Sajeev","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexcr.2025.114815_bib15","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1002\/ptr.7032","article-title":"Berberine-A potent chemosensitizer and chemoprotector to conventional cancer therapies","volume":"35","author":"Devarajan","year":"2021","journal-title":"Phytother Res."},{"key":"10.1016\/j.yexcr.2025.114815_bib16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jconrel.2019.12.011","article-title":"Mitochondria-targeting nanomedicine self-assembled from GSH-Responsive paclitaxel-ss-berberine conjugate for synergetic cancer treatment with enhanced cytotoxicity","volume":"318","author":"Cheng","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.yexcr.2025.114815_bib17","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/nature04716","article-title":"Crystal structure of an Hsp90-nucleotide-p23\/Sba1 closed chaperone complex","volume":"440","author":"Ali","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2025.114815_bib18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13045-018-0602-8","article-title":"Targeting the Hsp90-Cdc37-client protein interaction to disrupt Hsp90 chaperone machinery","volume":"11","author":"Li","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.yexcr.2025.114815_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-55026-y","article-title":"The dynamic triage interplay of Hsp90 with its chaperone cycle and client binding","volume":"15","author":"Qu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2025.114815_bib20","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.7150\/ijbs.77979","article-title":"Timosaponin AIII promotes non-small-cell lung cancer ferroptosis through targeting and facilitating HSP90 mediated GPX4 ubiquitination and degradation","volume":"19","author":"Zhou","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.yexcr.2025.114815_bib21","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/ijc.32227","article-title":"Inhibition of HSP90 overcomes resistance to chemotherapy and radiotherapy in pancreatic cancer","volume":"145","author":"Nagaraju","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yexcr.2025.114815_bib22","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1158\/0008-5472.CAN-06-4511","article-title":"High HSP90 expression is associated with decreased survival in breast cancer","volume":"67","author":"Pick","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2025.114815_bib23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ebiom.2017.09.007","article-title":"Plasma heat shock protein 90alpha as a biomarker for the diagnosis of liver cancer: an official, large-scale, and multicenter clinical trial","volume":"24","author":"Fu","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.yexcr.2025.114815_bib24","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1021\/acs.jmedchem.9b00940","article-title":"Heat shock protein 90 inhibitors: an update on achievements, challenges, and future directions","volume":"63","author":"Li","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.yexcr.2025.114815_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/13880209.2020.1865407","article-title":"Berberine regulates the Notch1\/PTEN\/PI3K\/AKT\/mTOR pathway and acts synergistically with 17-AAG and SAHA in SW480 colon cancer cells","volume":"59","author":"Li","year":"2021","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.yexcr.2025.114815_bib26","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1080\/15384047.2019.1595279","article-title":"Targeted blockade of HSP90 impairs DNA-damage response proteins and increases the sensitivity of ovarian carcinoma cells to PARP inhibition","volume":"20","author":"Gabbasov","year":"2019","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.yexcr.2025.114815_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20194812","article-title":"Proteasome inhibitors suppress ErbB family expression through HSP90-Mediated lysosomal degradation","volume":"20","author":"Huynh","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2025.114815_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101063","article-title":"Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer","volume":"73","author":"Ou","year":"2024","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.yexcr.2025.114815_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117277","article-title":"Berberine mitigates high glucose-induced podocyte apoptosis by modulating autophagy via the mTOR\/P70S6K\/4EBP1 pathway","volume":"243","author":"Li","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.yexcr.2025.114815_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110245","article-title":"Berberine represses human gastric cancer cell growth in vitro and in vivo by inducing cytostatic autophagy via inhibition of MAPK\/mTOR\/p70S6K and Akt signaling pathways","volume":"128","author":"Zhang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.yexcr.2025.114815_bib31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40659-019-0243-6","article-title":"Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells","volume":"52","author":"Liu","year":"2019","journal-title":"Biol. Res."},{"key":"10.1016\/j.yexcr.2025.114815_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2022.113217","article-title":"Berberine alkaloids inhibit the proliferation and metastasis of breast carcinoma cells involving Wnt\/\u03b2-catenin signaling and EMT","volume":"200","author":"Dian","year":"2022","journal-title":"Phytochemistry"},{"key":"10.1016\/j.yexcr.2025.114815_bib33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11274-024-04223-4","article-title":"Inhibitory effects of berberine on fungal growth, biofilm formation, virulence, and drug resistance as an antifungal drug and adjuvant with prospects for future applications","volume":"41","author":"Ding","year":"2024","journal-title":"World J. Microbiol. Biotechnol."},{"key":"10.1016\/j.yexcr.2025.114815_bib34","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1080\/15384047.2016.1210728","article-title":"Berberine reverses lapatinib resistance of HER2-positive breast cancer cells by increasing the level of ROS","volume":"17","author":"Zhang","year":"2016","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.yexcr.2025.114815_bib35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1749-8546-7-11","article-title":"Effects of Coptis extract combined with chemotherapeutic agents on ROS production, multidrug resistance, and cell growth in A549 human lung cancer cells","volume":"7","author":"He","year":"2012","journal-title":"Chin. Med."},{"key":"10.1016\/j.yexcr.2025.114815_bib36","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/s41419-021-04074-z","article-title":"Lamin-A interacting protein Hsp90 is required for DNA damage repair and chemoresistance of ovarian cancer cells","volume":"12","author":"Wang","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yexcr.2025.114815_bib37","doi-asserted-by":"crossref","first-page":"13650","DOI":"10.1073\/pnas.1203326109","article-title":"BRCA1 and HSP90 cooperate in homologous and non-homologous DNA double-strand-break repair and G2\/M checkpoint activation","volume":"109","author":"Stecklein","year":"2012","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.yexcr.2025.114815_bib38","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s12272-024-01494-1","article-title":"Combination therapy involving HSP90 inhibitors for combating cancer: an overview of clinical and preclinical progress","volume":"47","author":"Liu","year":"2024","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.yexcr.2025.114815_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.963719","article-title":"Analysis of the prognostic, diagnostic and immunological role of HSP90\u03b1 in malignant tumors","volume":"12","author":"Yuan","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.yexcr.2025.114815_bib40","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bcp.2012.03.011","article-title":"Inhibition of thymidine phosphorylase expression by using an HSP90 inhibitor potentiates the cytotoxic effect of cisplatin in non-small-cell lung cancer cells","volume":"84","author":"Weng","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.yexcr.2025.114815_bib41","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s13046-018-0880-6","article-title":"HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma","volume":"37","author":"Xiao","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448272500415X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448272500415X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T02:43:24Z","timestamp":1773629004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448272500415X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S001448272500415X"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2025.114815","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Berberine overcomes paclitaxel resistance in triple-negative breast cancer by inhibiting HSP90-mediated BRCA1 phosphorylation","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2025.114815","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114815"}}